Strength
.5 mg/.5mL
Manufacturer
Novo NordiskNDC
00169450514
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
SEMAGLUTIDEApproval Type
New Drug (NDA)
FDA Application
NDA215256On Market Since
6/5/2021
Pharmacological Classes
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
RYBELSUS 3 MG TABLET
Brand
00169430330•Novo Nordisk
$33.1602
per EA
RYBELSUS 14 MG TABLET
Brand
00169431430•Novo Nordisk
$33.1671
per EA
RYBELSUS 7 MG TABLET
Brand
00169430730•Novo Nordisk
$33.1730
per EA
SOLIQUA 100 UNIT-33 MCG/ML PEN
Brand
00024576105•Sanofi-Aventis U.S. LLC
$57.0731
per ML
XULTOPHY 100 UNIT-3.6 MG/ML PEN
Brand
00169291115•Novo Nordisk
$85.8558
per ML
SAXENDA 18 MG/3 ML PEN
Brand
00169280015•Novo Nordisk
$87.1538
per ML
VICTOZA 2-PAK 18 MG/3 ML PEN
Brand
00169406012•Novo Nordisk
$87.7373
per ML
VICTOZA 3-PAK 18 MG/3 ML PEN
Brand
00169406013•Novo Nordisk
$87.8351
per ML
BYETTA 10 MCG DOSE PEN INJ
Brand
00310652401•AstraZeneca Pharmaceuticals LP
$340.1014
per ML
TRULICITY 1.5 MG/0.5 ML PEN
Brand
00002143480•Eli Lilly and Company
$487.6298
per ML